<p style="font-weight: 400;">Researchers at the Spanish National Cancer Research Centre (CNIO), led by Dr. Mariano Barbacid, have achieved a <a href="https://www.dailymail.co.uk/health/article-15512253/Huge-pancreatic-cancer-breakthrough-scientists-achieve-permanent-disappearance-disease-new-triple-threat-approach.html">significant breakthrough</a> in the treatment of pancreatic ductal adenocarcinoma (PDAC), the most common and deadly form of pancreatic cancer. In a study <a href="https://www.pnas.org/doi/10.1073/pnas.2523039122">published</a> in the journal <em data-path-to-node="0" data-index-in-node="288">PNAS</em>, the team demonstrated that a new triple-drug combination therapy can completely and permanently eliminate pancreatic tumors in experimental mouse models.</p>
<p style="font-weight: 400;" data-path-to-node="1">Pancreatic cancer has long been considered one of the most difficult &#8220;incurable&#8221; diseases, characterized by a five-year survival rate of less than 11%. Its resilience is largely due to the KRAS oncogene, a mutation present in approximately 90% of cases. Although KRAS was historically considered &#8220;undruggable,&#8221; recent advances have enabled the development of RAS inhibitors. However, these single-target drugs often fail in the long term because tumors quickly develop resistance by utilizing alternative survival pathways.</p>
<p style="font-weight: 400;" data-path-to-node="2">The CNIO team’s innovation lies in a &#8220;triple-threat&#8221; approach that blocks three independent signaling nodes simultaneously: downstream (RAF1), upstream (EGFR), and orthogonal (STAT3) pathways. By targeting these three routes, the therapy effectively &#8220;traps&#8221; the cancer cells, preventing them from outmaneuvering the treatment. The researchers tested this across various models, including mice with human pancreatic tissue and mice genetically engineered to model the disease. In all cases, the combination — consisting of the drugs daraxonrasib (KRAS inhibitor), afatinib (EGFR inhibitor), and SD36 (STAT3 degrader) — resulted in complete tumor regression without the appearance of resistance for over 200 days post-treatment. Crucially, the therapy was well-tolerated with no significant toxicities.</p>
<p style="font-weight: 400;" data-path-to-node="3">The implications of this study are profound. Currently, patients rely on decades-old cytotoxic drugs like gemcitabine or highly toxic combinations like FOLFIRINOX, which offer limited benefits. This new research provides a roadmap for human clinical trials, suggesting that the key to curing pancreatic cancer lies in combination therapies rather than monotherapy.</p>
<p style="font-weight: 400;" data-path-to-node="4">While the results are promising, experts note limitations: the success was observed in healthy laboratory mice, and human physiology may present different challenges. Nevertheless, the Spanish government and the international scientific community have hailed the discovery as a potential turning point. If these results can be replicated in humans, it could transform the prognosis for a disease that currently kills more than half of its victims within three months of diagnosis.</p>

<script async src="https://www.instagram.com/embed.js"></script>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

‘Triple-Threat’ Breakthrough: New Therapy Eradicates Pancreatic Tumors In Preclinical Study

Popular ‘Healthy’ Fat Found To Fuel Deadly Pancreatic Cancer

How To Lose Your Mind: The World’s Simplest Impossible Math Problem

New Era For America: First New Reactor Goes Critical Under Trump’s Watch

Four Republicans Help Democrats Hide Behind The Filibuster — Then Mike Lee Drops The Hammer

State Department Slams U.K.’s ‘Two-Tiered Policing’ As Outrage Grows Over Henry Nowak Killing

Trump Targets Cuba’s Power Structure In Sweeping Blow To Communist Elites

News

Cancer

Pancreatic cancer

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Menu

— News —

‘Triple-Threat’ Breakthrough: New Therapy Eradicates Pancreatic Tumors In Preclinical Study